1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Alexion Pharmaceuticals Inc (ALXN)

  7. Alexion Pharmaceuticals Inc (ALXN) Financials

ALXN

Alexion Pharmaceuticals Inc
182.50
0.00 (0.0%)
Upgrade to Real-Time

Alexion Pharmaceuticals Inc. (ALXN) Fundamentals
Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions. Its blockbuster product, Soliris, is approved for paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). Next-generation Ultomiris is approved in PNH and aHUS. Strensiq and Kanuma target ultrarare metabolic diseases. Alexion's pipeline targets rare diseases with high unmet need in hematology, nephrology, metabolic diseases, neurology, cardiology, and other areas.
SHARE INFORMATION
Market CapUS$ 40,336,009,475
Shares Outstanding221,019,230
Float220,513,908
Percent Float99.77%
Short Interest9,803,110.00
Short Percent Float4.4%
Short Interest Ratio5.36
Short Interest Date2021-06-30
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 6,069,900,000
Latest Fiscal EPSUS$ 2.70
Latest Fiscal Date2020-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions1,965
Institutional Holdings Date2021-06-30
Institutional Bought Previous 3 Months43,792,261
Institutional Holdings Percent167.8%
Institutional Sold Previous 3 Months88,754,038
Insider Holdings Date2021-06-30
Insider Bought Previous 3 Months21,417
Insider Holdings Percent1.3
Insider Sold Previous 3 Months6,303
Insider Shares Owned2,976,819
TRADING INFO
52 Week HighUS$ 0.00
52 Week LowUS$ 0.00
52 Week High ChangeUS$ 0.00
21 Day Moving AverageUS$ 0.00
21 Day Extended Moving AverageUS$ 182.50
50 Day Moving AverageUS$ 0.00
50 Day Extended Moving AverageUS$ 182.50
200 Day Moving AverageUS$ 0.00
200 Day Extended Moving AverageUS$ 181.7246
10 Day Average Volume-
20 Day Average Volume-
30 Day Average Volume-
50 Day Average Volume-
Alpha-0.001805
Beta1.3359
Standard Deviation0.107254
R20.393602
7 Day Price ChangeUS$ 0.00
7 Day Percent Change0.0%
21 Day Price ChangeUS$ 0.00
21 Day Percent Change0.0%
30 Day Price ChangeUS$ 0.00
30 Day Percent Change0.0%
Month to Date Price ChangeUS$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price ChangeUS$ 0.00
Quarter to Date Percent Change0.0%
180 Day Price ChangeUS$ 0.00
180 Day Percent Change0.0%
200 Day Price ChangeUS$ 0.00
200 Day Percent Change0.0%
Year to Date Price ChangeUS$ 0.00
Year to Date Percent Change0.0%

Alexion Pharmaceuticals Inc. (ALXN) Key Ratios

PROFITABILITY
EBIT Margin9.8%
EBITDA Margin14.8%
Pre-Tax Profit Margin24.1%
Profit Margin Count33.28%
Gross Margin90.9%
Profit Margin TOT33.28%
INCOME STATEMENTS
RevenueUS$ 4,817,000,000
Revenue Per ShareUS$ 21.7945
Revenue (3 Years)US$ 13.80
Revenue (5 Years)US$ 15.22
FINANCIAL STRENGTH
Price to Tangible Book9.50
Total Debt To Equity0.20
Int Coverage5.80
Current Ratio4.50
Leverage Ratio1.50
Quick Ratio3.50
Long Term Debt To Capital0.17
VALUATION MEASURES
PE Ratio59.60
Enterprise ValueUS$ 39,569,509,475
Price to Sales8.3737
Price to Free Cash49.90
PE High Last 5 Years429.90
Price To Book3.30
Price To Cash Flow13.10
PE Low Last 5 Years6.80
Price to Tangible Book9.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.50
Invoice Turnover0.70
Assets Turnover0.10
Return Assets3.71
Return on Equity5.64
Return on Capital5.05

Alexion Pharmaceuticals Inc. (ALXN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEOLudwig N. Hantson
Emplyoees3837
Last AuditUE
CIK0000899866
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address121 Seaport Boulevard
Boston, MA 2210
Websitehttps://www.alexion.com
Facsimile+1 203 271-8198
Telephone+1 475-230-2596
EmailInvestorRelations@alexion.com
Your Recent History
NASDAQ
ALXN
Alexion Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 01:28:39